Published Date:2022-03-04 Original Link:https://www.onenessbio.com/en/news_detail147_3.htm No 1 Date of announcement 2022/03/04 Time of announcement 17:13:42 Subject The Malaysia National Pharmaceutical Regulatory Agency has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon To which item it meets paragraph 10 Date of events 2022/03/04 Statement Product:ON101 Diabetic foot ulcer new drug Mass production date:NA...Read More